Allianz Asset Management GmbH - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 10 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$25,869,000
-44.2%
31,765,000
-37.7%
0.04%
-16.7%
Q4 2019$46,392,000
-2.2%
50,980,0000.0%0.04%
-10.6%
Q3 2019$47,431,000
-4.9%
50,980,0000.0%0.05%
+2.2%
Q2 2019$49,896,000
+2.6%
50,980,000
+1.5%
0.05%
-4.2%
Q1 2019$48,641,00050,230,0000.05%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Opti Capital Management, LP 46,902,000$45,737,0004.40%
INCOME RESEARCH & MANAGEMENT 7,500,000$7,280,0003.12%
TENOR CAPITAL MANAGEMENT Co., L.P. 96,994,000$94,477,0002.13%
PIPER SANDLER & CO. 2,200,000$2,112,0001.92%
DeepCurrents Investment Group LLC 41,092,000$39,934,0001.59%
Radcliffe Capital Management, L.P. 69,010,000$66,983,0001.54%
Sonora Investment Management Group, LLC 9,635,000$9,389,0000.89%
Penn Mutual Asset Management 675,000$656,0000.88%
OAKTREE CAPITAL MANAGEMENT LP 24,447,000$23,851,0000.28%
WOLVERINE ASSET MANAGEMENT LLC 8,681,000$8,429,0000.08%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders